Under construction – not a live service
Sign in
Taking people in FranceNo phase

How self-awareness relates to social understanding in frontotemporal dementia and Alzheimer's disease

Studies self-awareness and social skills in people with behavioral frontotemporal dementia or Alzheimer's disease.

Plain-language title generated from the registry record
Registry title: Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases

Key facts

Where
Paris, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 80 years old?

Source: NCT07531732, who can take part

Where in France

  • Cognitive Neurology Center, Lariboisière-Fernand Widal Hospital Group, APHPParis, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assistance Publique - Hôpitaux de Paris
Trial code
NCT07531732
Record updated
15 April 2026
Original description
This monocentric, non-interventional study (SELFSOC) investigates the relationship between self-awareness and social cognition in patients with behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD).Read full original descriptionShow less

Study of the Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases in People With Frontotemporal Lobar Degeneration, Behavioral Variant and Alzheimer's Disease

This monocentric, non-interventional study (SELFSOC) investigates the relationship between self-awareness and social cognition in patients with behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD).

The primary objective is to assess metacognitive efficiency related to social cognitive performance using a computerized facial emotion recognition task combined with confidence judgments. Metacognitive indices (including Mratio) will quantify the correspondence between subjective and objective performance.

Thirty-four participants (17 bvFTD, 17 AD; age 50-80; MMSE ≥20) will complete two study visits involving tasks assessing emotion recognition, theory of mind, and memory.

Inclusion: Diagnosis of possible or probable behavioral variant frontotemporal dementia according to the Rascovsky 2011 criteria (DLFTvc group) OR; Diagnosis of Alzheimer's disease according to the Jack 2018 criteria, including biomarkers (MA group); Mini-Mental State Examination (MMSE) ≥ 20; Age: 50-80 years; Sufficient reading and writing proficiency in French to enable completion of the study procedures, in the investigator's opinion.

Exclusion: Moderate to severe language disorders: Confrontation naming (DO 40 scale) ≤ 32; Other neurological disorders (including epilepsy, Lewy body disease, vascular dementia); Psychiatric comorbidities (bipolar disorder, schizophrenia, current major depressive episode); Uncorrected visual impairment; Inability to perform computerized tasks according to the investigator's opinion.

ClinicalTrials.gov NCT07531732